Рассеянный склероз и другие демиелинизирующие болезни: литература
Beck RW et al: A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 326:581, 1992
Fazekas F et al: Randomized placebo-controlled trial of monthly intravenous immunogloubin therapy in relapsing-remitting multiple sclerosis. Science 349:589, 1997
Goodkin DE, Rudick RA(eds): Treatment of Multiple Sclerosis: Advances in Trial Design, Results and Future Perspectives. London, Springer-Verlag, 1996
IFNbeta Multiple Sclerosis Study Group: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:655, 1993
Jacobs LD et al: Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285, 1996
Johnson KP et al: Copolymer I reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis. Results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268, 1995
Johnson RT et al: Measles encephalomyelitis: Clinical and immunologic studies. N Engl J Med 310:137, 1984
Matthews WB et al: McAlpine 's Multiple Sclerosis. New York, Churchill Livingstone, 1991
Paty DW et al: Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662, 1993
The Multiple Sclerosis Genetics Group: A complete genomic screen for multiple sclerosis underscores a role for the major histocompa-tibility complex. Nature Genet 13:469, 1996
Waxman SG: Clinical course and electrophysiology of multiple sclerosis. Adv Neurol 47:1, 1988
